NM_004364.5:c.*86C>T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_004364.5(CEBPA):​c.*86C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000676 in 1,332,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )

Consequence

CEBPA
NM_004364.5 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: -0.460

Publications

0 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA Gene-Disease associations (from GenCC):
  • acute myeloid leukemia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004364.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
NM_004364.5
MANE Select
c.*86C>T
3_prime_UTR
Exon 1 of 1NP_004355.2
CEBPA
NM_001287424.2
c.*86C>T
3_prime_UTR
Exon 1 of 1NP_001274353.1P49715-4
CEBPA
NM_001287435.2
c.*86C>T
3_prime_UTR
Exon 1 of 1NP_001274364.1P49715-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
ENST00000498907.3
TSL:6 MANE Select
c.*86C>T
3_prime_UTR
Exon 1 of 1ENSP00000427514.1P49715-1
ENSG00000267727
ENST00000587312.1
TSL:3
n.-27G>A
upstream_gene
N/A
ENSG00000267580
ENST00000589932.1
TSL:2
n.*84G>A
downstream_gene
N/A

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000676
AC:
9
AN:
1332046
Hom.:
0
Cov.:
31
AF XY:
0.00000768
AC XY:
5
AN XY:
650758
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30338
American (AMR)
AF:
0.0000650
AC:
2
AN:
30758
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21588
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35302
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70454
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31454
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4246
European-Non Finnish (NFE)
AF:
0.00000570
AC:
6
AN:
1052380
Other (OTH)
AF:
0.0000180
AC:
1
AN:
55526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Acute myeloid leukemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.6
DANN
Benign
0.80
PhyloP100
-0.46
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs991316142; hg19: chr19-33792158; API